- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01349712
Study to Test the Accuracy of a Prototype Handheld PT/INR Device
May 5, 2011 updated by: Universal Biosensors Pty Ltd
Correlation of Feasibility Batches Using Warfarinised Blood
The purpose of this study is to measure prothrombin time (PT) on an experimental device and a commercially available device on persons receiving coumadin (warfarin)treatment.
Study Overview
Status
Unknown
Conditions
Detailed Description
This study will require participants to have up to 2 finger-punctures taken and sample tested on a strip and meter system for both the experimental and commercially available devices.
Study Type
Observational
Enrollment (Anticipated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arkansas
-
Batesville, Arkansas, United States, 72501
- White River Diagnostic Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Subjects currently receving coumadin(warfarin) treatment
Description
Inclusion Criteria:
- Currently taking coumadin (warfarin)
- Aged 18 years or older
- Able and willing to provide informed consent
- Can understand (read and write) English
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Coumadin (warfarin)
Subjects are required to be currently receiving coumadin (warfarin) treatment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PT/INR values from the experimental device will be statistically correlated to results obtained from a commercially available device
Time Frame: Fives days to collect data and up to two weeks to generate correlation graph
|
To determine the correlation of PT/INR values between an experimental and commercial device.
|
Fives days to collect data and up to two weeks to generate correlation graph
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Richard Ward, Pharm D, Harding University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2011
Primary Completion (Anticipated)
November 1, 2011
Study Completion (Anticipated)
November 1, 2011
Study Registration Dates
First Submitted
April 29, 2011
First Submitted That Met QC Criteria
May 5, 2011
First Posted (Estimate)
May 9, 2011
Study Record Updates
Last Update Posted (Estimate)
May 9, 2011
Last Update Submitted That Met QC Criteria
May 5, 2011
Last Verified
May 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MOB 0158
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Coagulation Disorders
-
VarmX B.V.RecruitingCoagulation DisorderNetherlands
-
Groupe Hospitalier Paris Saint JosephCompletedCoagulation DisorderFrance
-
Cairo UniversityRecruitingCoagulation DisorderEgypt
-
Stony Brook UniversityCompletedCoagulation DisorderUnited States
-
HemoSonics LLCCompleted
-
TakedaTakeda Development Center Americas, Inc.RecruitingCoagulation DisorderUnited States, Spain, Belgium, France, Netherlands
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
VarmX B.V.Completed
-
HemoSonics LLCIRCCS Policlinico S. DonatoCompletedCoagulation DisorderItaly